Learning Objectives:

  • Understand why it is crucial to diagnose immunological disorders in patients with Thymic Epithelial Tumors (TET)

  • Be able to list and describe common immunological disorders in patients with TETs, such as Pure Red Cell Aplasia (PRCA), and Good Syndrome 

  • Understand the potential benefits and risks of using immunotherapy in patients with Thymic Epithelial Tumors

Session date: 
07/29/2024 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Erica Pietroluongo, MD